These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5965137)

  • 1. Studies on plasminogen activators. I. Sucrose density gradient distribution of activators from normal and lytic human plasma.
    Hamberg U
    Acta Chem Scand; 1966; 20(9):2539-50. PubMed ID: 5965137
    [No Abstract]   [Full Text] [Related]  

  • 2. Separation of plasminogen activators from normal and lytic human plasma.
    Hamberg U
    Life Sci; 1966 Apr; 5(8):731-41. PubMed ID: 5961369
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on plasminogen activators. IV. An enzyme complex with exterase activity in streptokinase-activated human plasma.
    Hamberg U; Savolainen ML
    Acta Chem Scand; 1967; 21(10):2902-3. PubMed ID: 4231062
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 5. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of bovine plasminogen activator from a human plasminogen-streptokinase mixture.
    Ling CM; Summaria L; Robbins KC
    J Biol Chem; 1967 Apr; 242(7):1419-25. PubMed ID: 4960668
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reaction kinetics of activator formation in streptokinase-induced fibrinolysis].
    Martin M
    Verh Dtsch Ges Inn Med; 1972; 78():717-9. PubMed ID: 4665739
    [No Abstract]   [Full Text] [Related]  

  • 10. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
    Kaplan AP; Austen KF
    J Exp Med; 1972 Dec; 136(6):1378-93. PubMed ID: 4264575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on plasminogen activators. II. A method for the separation of purified urokinase from small samples of urine.
    Hamberg U; Savolainen ML
    Acta Chem Scand; 1966; 20(9):2551-8. PubMed ID: 5965138
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen in human saliva.
    Moody GH
    Int J Oral Surg; 1982 Apr; 11(2):110-4. PubMed ID: 6809670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN; Cederholm-Williams SA; Allington MJ; Sharp AA
    Thromb Res; 1977 Mar; 10(3):421-30. PubMed ID: 854878
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effects of the acylated streptokinase-plasminogen activator complex BRL 33 575 incubated with normal human plasma.
    Lämmle B; Noll G; Tran TH; Lohri A; Duckert F
    Thromb Haemost; 1984 Jul; 51(3):403-5. PubMed ID: 6548585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of SK-plasminogen-complex in sera and euglobulin solution of cat and monkey by gel filtration using sephadex G-200.
    Nitta H; Sugie I; Ikai M; Ozio M; Takahashi N
    Nagoya Med J; 1969 Jul; 15(2):93-102. PubMed ID: 4981466
    [No Abstract]   [Full Text] [Related]  

  • 16. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
    Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
    J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to the molecular chemistry of coagulation and fibrinolysis.
    Müllertz S
    Scand J Clin Lab Invest; 1968; 22(1):1-3. PubMed ID: 4236696
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma concentration of coagulation and fibrinolysis factors and platelet function in hypertension.
    van Wersch JW; Rompelberg-Lahaye J; Lustermans FA
    Eur J Clin Chem Clin Biochem; 1991 Jun; 29(6):375-9. PubMed ID: 1912085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
    Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J
    Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.